Millipore Sigma Vibrant Logo

613450 TOFA - CAS 54857-86-2 - Calbiochem

A cell-permeable furoic acid compound that acts as a potent, reversible, and competitive inhibitor of acetyl-CoA carboxylase (ACC), a key enzyme involved in the fatty acid biosynthesis.

TOFA - CAS 54857-86-2 - Calbiochem: MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.

Sinonimi: 5-(Tetradecyloxy)-2-furoic acid

Primary Target: Acetyl-CoA carboxylase (ACC)
View Products on Sigmaaldrich.com
613450
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Tabella delle specifiche principali

CAS #Empirical Formula
54857-86-2C₁₉H₃₂O₄

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
613450-5MG
Verifica della disponibilità in corso...
—
Disponibilità limitata Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      		 Fiala di plastica 5 mg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      —
      Richiedi il prezzo
      		 —
      Description
      OverviewA cell-permeable furoic acid compound that acts as a potent, reversible, and competitive inhibitor of acetyl-CoA carboxylase (ACC), a key enzyme involved in the fatty acid biosynthesis. Inhibits cellular fatty acid synthesis in a dose-dependent manner (IC50 = 4 µM in human breast cancer cell line MCF7). TOFA-induced reduction in malonyl-CoA is reported to off-set the effect of C75 (Cat. No. 341325) on food intake in fasted mice and on apoptosis in tumor cells.
      Catalogue Number613450
      Brand Family Calbiochem®
      Synonyms5-(Tetradecyloxy)-2-furoic acid
      References
      ReferencesLandree, L.E., et al. 2004. J. Biol. Chem. 279, 3817.
      Zhou, W., et al. 2003. Cancer Res. 63, 7330.
      Hu, Z., et al. 2003. Proc. Natl. Acad. Sci. USA 100, 12624.
      Pizer, E.S., et al. 2000. Cancer Res. 60, 213.
      Arbeeny, C.M., et al. 1992. J. Lipid Res. 33, 843.
      Fukuda, N. and Ontko, J.A. 1984. J. Lipid Res. 25, 831.
      Product Information
      CAS number54857-86-2
      ATP CompetitiveY
      FormOff-white solid
      Hill FormulaC₁₉H₃₂O₄
      Chemical formulaC₁₉H₃₂O₄
      ReversibleY
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetAcetyl-CoA carboxylase (ACC)
      Primary Target IC<sub>50</sub>4 µM inhibiting cellular fatty acid synthesis in human breast cancer cell line MCF7
      Purity≥98% by HPLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Carcinogenic / Teratogenic
      Storage +2°C to +8°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      613450-5MG 04055977263787

      Documentation

      TOFA - CAS 54857-86-2 - Calbiochem MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      TOFA - CAS 54857-86-2 - Calbiochem Certificati d'Analisi

      TitoloNumero di lotto
      613450

      Riferimenti bibliografici

      Panoramica delle referenze
      Landree, L.E., et al. 2004. J. Biol. Chem. 279, 3817.
      Zhou, W., et al. 2003. Cancer Res. 63, 7330.
      Hu, Z., et al. 2003. Proc. Natl. Acad. Sci. USA 100, 12624.
      Pizer, E.S., et al. 2000. Cancer Res. 60, 213.
      Arbeeny, C.M., et al. 1992. J. Lipid Res. 33, 843.
      Fukuda, N. and Ontko, J.A. 1984. J. Lipid Res. 25, 831.
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision03-November-2014 JSW
      Synonyms5-(Tetradecyloxy)-2-furoic acid
      DescriptionA cell-permeable, potent, reversible, and competitive inhibitor of acetyl-CoA carboxylase (ACC), a key enzyme involved in fatty acid biosynthesis. Inhibits cellular fatty acid synthesis in a dose-dependent manner (IC50 = 4 µM in human breast cancer cell line MCF7). TOFA-induced reduction in malonyl-CoA is reported to off-set the effects of C75 (Cat. No. 341325) on food intake in fasted mice and on apoptosis in tumor cells.
      FormOff-white solid
      Intert gas (Yes/No) Packaged under inert gas
      CAS number54857-86-2
      Chemical formulaC₁₉H₃₂O₄
      Structure formulaStructure formula
      Purity≥98% by HPLC
      SolubilityDMSO (10 mg/ml) or Ethanol (5 mg/ml). Slight warming and sonication may be required for complete solubilization in ethanol.
      Storage Protect from light
      +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Carcinogenic / Teratogenic
      ReferencesLandree, L.E., et al. 2004. J. Biol. Chem. 279, 3817.
      Zhou, W., et al. 2003. Cancer Res. 63, 7330.
      Hu, Z., et al. 2003. Proc. Natl. Acad. Sci. USA 100, 12624.
      Pizer, E.S., et al. 2000. Cancer Res. 60, 213.
      Arbeeny, C.M., et al. 1992. J. Lipid Res. 33, 843.
      Fukuda, N. and Ontko, J.A. 1984. J. Lipid Res. 25, 831.